GlassScriptPhysician profile
Irina Dukhovny
NPI 1922102441
$3,042.30
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,400 · 2020: $539 · 2021: $562 · 2022: $542.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $250.58 | 2019-2022 | |
| Allergan, INC. | $237.35 | 2019 | |
| Neurocrine Biosciences, INC. | $236.19 | 2019-2022 | |
| Adamas Pharmaceuticals, INC. | $235.06 | 2019 | |
| Scilex Pharmaceuticals INC. | $234.57 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $229.61 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $159.38 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $135.81 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $127.26 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $123.97 | 2020 | |
| Novartis Pharmaceuticals Corporation | $120.99 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $117.92 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $94.44 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $92.08 | 2020-2022 | |
| Lilly USA, LLC | $84.08 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $80.89 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $79.90 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $70.83 | 2019 | |
| Amgen INC. | $68.44 | 2019 | |
| Ucb, INC. | $65.04 | 2019 | |
| Abbvie INC. | $41.80 | 2021-2022 | |
| Kyowa Kirin, INC. | $26.20 | 2019 | |
| Lundbeck LLC | $24.56 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.92 | 2022 | |
| Vertical Pharmaceuticals, LLC | $21.93 | 2019 | |
| Sk Life Science, INC. | $21.37 | 2020 | |
| Merck Sharp & Dohme LLC | $20.68 | 2022 | |
| Pfizer INC. | $18.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Dukhovny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.